Agenus Inc header image

Agenus Inc

AGEN

Equity

ISIN US00847G8042 / Valor 134326284

NASDAQ (2024-09-18)

USD 6.05-2.89%

Agenus Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Agenus Inc is a biotechnology firm focused on the discovery, manufacturing, and development of immuno-oncology (I-O) therapeutics. The company aims to enhance the efficacy of cancer treatments by employing a comprehensive approach that includes a variety of therapeutic modalities. These include a broad array of antibody therapeutics, adoptive cell therapies—which are advanced through its subsidiary MiNK Therapeutics—as well as adjuvants and vaccines, developed with the expertise of another subsidiary, SaponiQx. Agenus's strategy revolves around leveraging these diverse platforms to develop combination therapies that can potentially benefit a wider patient population by targeting various aspects of the immune system to fight cancer more effectively.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-75.8%1Y

-94.7%3Y

-89.6%5Y

Performance

142%1Y

105%3Y

92.8%5Y

Volatility

2072 M

Market cap (USD)

101,067

Daily traded volume (Shares)

6.46 / 5.88

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

GSK PLC

GSK PLC Valor: 119642297

Annual Return

-50%0%+50%

Risk level

110

-0.34%GBP 16.04

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

-1.15%GBP 11.63

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

-0.34%GBP 7.25

CVS Group PLC

CVS Group PLC Valor: 3457960

Annual Return

-50%0%+50%

Risk level

110

2.45%GBP 11.72

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd Valor: 2318407

Annual Return

-50%0%+50%

Risk level

110

2.38%GBP 0.21

Sareum Holdings PLC

Sareum Holdings PLC Valor: 116566624

Annual Return

-50%0%+50%

Risk level

110

-3.70%GBP 0.26

Venture Life Group PLC

Venture Life Group PLC Valor: 23084203

Annual Return

-50%0%+50%

Risk level

110

-1.34%GBP 0.48

MedNation AG

MedNation AG Valor: 331107

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 1.46

Viking Therapeutics Inc

Viking Therapeutics Inc Valor: 24839858

Annual Return

-50%0%+50%

Risk level

110

2.40%USD 64.45

Protagonist Therapeutics Inc

Protagonist Therapeutics Inc Valor: 33278818

Annual Return

-50%0%+50%

Risk level

110

-0.31%USD 44.77

SIX

FactSet

Clearbit

Logos provided by Clearbit